Skip to the main content.

Esophageal Cancer

PHASE 3

Case Studies

Here you can edit the background of the section

Key Takeaways

BBK was engaged to support enrollment in South Korea for a study of a PD-1 immune checkpoint inhibitor in patients with esophageal cancer refractory or intolerant to common treatment.

To generate awareness, BBK developed a program that directed physicians to alert their eligible patients about the study and encourage them to contact principal investigators directly.

Esophageal Cancer Website for Referring Physicians

Esophageal Cancer Oncologist




 

 

Challenges 

 

  • Patients will likely have established relationships with their treating physicians. Therefore, accessing referring physician networks and patient panels will be critical for success.

  • Family members are typically involved in the patient’s care, and it will be important to engage their interest.

  • During campaign development, there were unexpected operational adjustments (e.g., changes to outreach tactics and the physician-facing study website) that required a flexible response.

  • During deployment, the sponsor requested that timelines be accelerated by two weeks — reducing the full amount of time to generate referrals.

 

Solutions and Impact

Leveraging BBK’s network of Korean physicians who specialize in esophageal cancer, BBK identified, evaluated and reached out to 105 physicians with direct-to-physician emails. Additionally, we conducted 157 phone calls with Korean physicians and site staff to raise awareness for the study and to encourage referrals.

In just six weeks, the physician website had 47 unique visitors. 27 physicians expressed interest in referring 1 or more of their patients to the study, exceeding expectations.

 

  • Participants_ICON 27 INTERESTED PHYSICIANS

  • Sites_ICON 7 SITES

  • Countries-ICON-1 1 COUNTRY (SOUTH KOREA)

  • Calendar_ICON 6 WEEKS OF SUPPORT

Extensive Oncology Experience

Our experience informs our messaging platforms, flexible solutions and patient-centric support, which drive recruitment and engagement success. We take a protocol-specific approach in order to ensure our recommendations align with patient needs and deliver a positive patient experience.

 

 

Download the PDF version of this case study today:

Subscribe to stay connected

Share this page:

Familial Amyloid Polyneuropathy — Neurology and Gene Therapy — Phase 3

case-studies-icon Case Studies

March 23, 2023

Pediatric Spinal Muscular Atrophy — Neurology and Rare Disease — Phase 2

case-studies-icon Case Studies

March 23, 2023

Major Depressive Disorder — Mental Health — Pivotal Phase 3 Study

case-studies-icon Case Studies

March 23, 2023

BBK Worldwide, LLC
117 Kendrick St., Suite 600
Needham, MA 02494 United States

        Terms & Conditions  Privacy Policy

        © 2023 BBK Worldwide. BBK Worldwide is a Publicis Health company.

        Facebook LinkedIn YouTube
        Facebook LinkedIn YouTube

        Terms & Conditions  Privacy Policy

        © 2023 BBK Worldwide. BBK Worldwide is a Publicis Health company.